Monday, March 23, 2026

Llama 4 Goes MoE: Meta Slashes Compute Costs in New AI Models

Meta launches Llama 4 AI models, optimizing costs and performance, while aiming to enhance interactive voice capabilities.

North Korea Unveils Its First Rum: A $1, 40% Spirit That Signals a New Consumer-Goods Experiment

North Korea introduces its first sugarcane-based rum, signaling diversification in its liquor industry and potential market expansion.

WHO CARES WHAT LEE THINKS? Trump Admin Plans North Korea Policy—But South Korea Just Begs For Meetings

The US and South Korea are considering regular meetings to discuss their overall North Korea policy.

Tag: SJN314

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Top News

- Our Sponsors Ad -

Follow us